Agios Pharmaceuticals



Ebitda Changement Date
AbbVie USD 6.92B 258M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Arrowhead Research USD -156177000 1M 2024-12
Astellas Pharma JPY 110.79B 173.83B 2025-03
AstraZeneca USD 5.26B 597M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 6.17B 1.27B 2024-12
Exelixis USD 171.1M 24.2M 2025-01
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
Incyte USD 320.2M 128.19M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Merck USD 7.12B 1.06B 2024-12
Moderna USD -993000000 1.19B 2024-12
Novartis USD 5.19B 319M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Agios Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.